Sagility
BSE 544282 · ISIN INE0W2G01015
16 stories, newest first.
- TDS on interim dividend: Rs. 0.15 per share, record date October 30, 2026
- Sagility reported steady quarterly results with margin improvement and raised full-year EBITDA margin guidance
- Sagility posts recording of Oct 22, 2026 Q2 FY2026-27 earnings webinar on website
- Sagility reported strong Q2 numbers and raised FY27 adjusted EBITDA margin guidance
- Board declares interim dividend of ₹0.15 per share for FY 2026-27
- Record date for interim dividend fixed at October 30, 2026; Rs. 0.15 per share for FY2026-27
- Board declares ₹0.15 per share interim dividend for FY 2026-27
- Q2 FY27 results: revenue up 22.5% YoY, adjusted EBITDA margin 26.3%, interim dividend of ₹ 0.15 per share
- Sagility Q2 FY27 revenue up 22.5% to ₹20,321 million; adjusted EBITDA margin at 26.3%
- Board approves Q2 and H1 results, declares ₹0.15 interim dividend
- Sagility Ltd press release
- Sagility to buy 100% of Chirok Health LLC for up to US$ 32.35 M in cash
- Sagility to host Q2 FY27 earnings webinar for analysts and investors on October 22, 2026 at 7:30 PM IST
- Board meeting on October 22 to consider September-quarter results and interim dividend proposal
- Nuvama initiated a buy on Sagility with target price of Rs 60, citing deep payer relationships and growth visibility
- Global General Counsel change: Daniel B. Bailey resigns, Brian Clayton appointed as SMP
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.